AZ
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
244.37
Exchange
XLON - London Stock Exchange
7.1 B
Last period Cash and equivalents ,USD
13%
Cash and equivalents has increased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also AstraZeneca
Company Analysis
AZN.L valuation, rating, competitors, insights and company profile
Eyestock Rating
AZN.L financial analysis by Eyestock methodology
Valuation
AZN.L valuation using historical relative method
Statements
AZN.L Income Statements, Balance Sheet and Cash Flow Statements
Dividends
AZN.L dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
AstraZeneca`s Cash and equivalents for the period ended 2024-06-30 are 7.1 B USD
